Tumour growth inhibition and anti-metastatic activity of a mutated furin-resistant Semaphorin 3E isoform. - Wikidata - wikimedia - TriplyDB

Tumour growth inhibition and anti-metastatic activity of a mutated furin-resistant Semaphorin 3E isoform.

Tumour growth inhibition and anti-metastatic activity of a mutated furin-resistant Semaphorin 3E isoform.

http://www.wikidata.org/entity/Q36037975

about

Anti-angiogenesis and metastasis: a tumour and stromal cell alliance Control of cellular motility by neuropilin-mediated physical interactions Semaphorin-3D and semaphorin-3E inhibit the development of tumors from glioblastoma cells implanted in the cortex of the brain.Identification and characterization of alternative exon usage linked glioblastoma multiforme survival Exploiting pleiotropic activities of semaphorins as multi-target therapies for cancer Epigenetically downregulated Semaphorin 3E contributes to gastric cancer Novel intrathecal and subcutaneous catheter delivery systems in the mouse Current drug design to target the Semaphorin/Neuropilin/Plexin complexes.Controlling escape from angiogenesis inhibitors.Overexpression of Semaphorin-3E enhances pancreatic cancer cell growth and associates with poor patient survival Plexin structures are coming: opportunities for multilevel investigations of semaphorin guidance receptors, their cell signaling mechanisms, and functions.The role and mechanism-of-action of Sema3E and Plexin-D1 in vascular and neural development.The role of semaphorins and their receptors in vascular development and cancer.Semaphorin receptors meet receptor tyrosine kinases on the way of tumor progression.The emerging role of class-3 semaphorins and their neuropilin receptors in oncology.The potential of class 3 semaphorins as both targets and therapeutics in cancer.The role of the semaphorins in cancer.The proprotein convertase furin in tumour progression.Role of the nervous system in cancer metastasis.Bad vessels beware! Semaphorins will sort you out!Mechanistic basis for the potent anti-angiogenic activity of semaphorin 3F View Point: Semaphorin-3E: An Emerging Modulator of Natural Killer Cell Functions?New functions of Semaphorin 3E and its receptor PlexinD1 during developing and adult hippocampal formation.Semaphorin-3E attenuates neointimal formation via suppressing VSMCs migration and proliferation.Experimental Approaches for Studying Semaphorin Signals in Tumor Growth and Metastasis in Mouse Models.Characterization of Semaphorin 6A-Mediated Effects on Angiogenesis Through Regulation of VEGF Signaling.Cancer: Limitations of therapies exposed

P2860

Q26862741-C223F877-A990-46AE-9C61-7044A0510521 Q27027713-C1C16B64-CBCF-426D-9DB5-5C57D5C510EF Q31088312-DB1608D9-3BF6-420D-A8D8-9DA587D57320 Q34498701-38874284-DDB9-4E62-90DB-CEE595420819 Q36037962-E282F55C-0B76-49C2-B957-D19BBB6036C2 Q36299715-5E7BDBE5-26C2-457C-B5B1-2AE1739748D8 Q37238590-35D5482A-02DA-4376-AE4E-C639AF711CFF Q37509064-C60EAB47-31C4-4545-A7B9-F86284AF5845 Q37672654-5291563C-0D61-48D8-9A8E-EDF35AE47FD3 Q37699442-4AAB4F9C-6E8C-4988-8BE8-AA8D2DC41BCE Q38022543-7A57A0A8-748C-40B9-BD5A-07792F66D1FB Q38070018-BCE89434-F321-4337-81AE-7787EAA9BDA2 Q38082866-A053A13E-21A4-44BC-B98D-DB8F4971A2F7 Q38161405-BBD39D2D-9535-4AEB-9E54-C316E60E56DA Q38256958-71942DA2-B601-4201-BC7E-D40083E82E71 Q38272709-6DCA5207-D0B8-40FB-AD3F-704417326B50 Q38929961-583D8AC9-39F6-4960-846E-3DB0ECA0EA6A Q39215671-FB3B2FB2-F817-40F7-A50E-7A891DE23948 Q39914415-C7F8F7B3-FDF2-4DA9-B622-2FA0C497540C Q42592347-16B13600-B39A-4E13-A584-41423B7B242B Q42773855-159CBE3B-69C9-4EEB-B4BA-5E4853E59EA0 Q47104862-1704E4EC-3447-40EC-84D9-D6220749E380 Q48190696-215B89FA-058C-4143-A8F3-4F9A7BF8AC12 Q50089075-2B542C35-C708-43F5-8A32-70E8B5B1B487 Q52859593-2B08E1E8-3485-49B2-908D-0317AB1CCAA9 Q52859607-55D47FB2-57D5-479D-A134-B6F65D88A2AB Q59086317-DCADFBBA-F0FD-4F7E-8D49-2E5807F8EA12

P2860

Tumour growth inhibition and anti-metastatic activity of a mutated furin-resistant Semaphorin 3E isoform.

http://www.wikidata.org/entity/Q36037975

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Tumour growth inhibition and a ...... sistant Semaphorin 3E isoform.

@ast

Tumour growth inhibition and a ...... sistant Semaphorin 3E isoform.

@en

type

label

Tumour growth inhibition and a ...... sistant Semaphorin 3E isoform.

@ast

Tumour growth inhibition and a ...... sistant Semaphorin 3E isoform.

@en

prefLabel

Tumour growth inhibition and a ...... sistant Semaphorin 3E isoform.

@ast

Tumour growth inhibition and a ...... sistant Semaphorin 3E isoform.

@en

P1433

Q36037975-F0BBAFF7-5958-4C8F-887B-4E3BAE8BFD34

P1476

Q36037975-DEC751BB-7CB9-4D39-95B8-A9F96844D188

P2093

Q36037975-0DE1644A-DFA4-43F3-B964-62110FC32EA2

Q36037975-25428150-3245-47B1-9FDD-2FCD7494CDB7

Q36037975-53AA66D0-940A-492A-8EAB-F86D91F67E15

Q36037975-56308038-AF95-4398-9BE7-73857294CBCB

Q36037975-7A86246F-041E-4F35-9DAC-DA4651E138AC

Q36037975-8DB2D13C-C97E-4A03-B4F0-996C1D31092D

Q36037975-C168243D-C27D-4182-95C1-311BB09BA4B5

Q36037975-CDDD88A2-7178-4B89-9852-DDEE9956F1B7

Q36037975-FBA3A319-C810-43F8-BBD4-71C817E5B338

P2860

Q36037975-0660D38F-0EEF-430E-8FBB-58BFD04A8DC3

Q36037975-1193268D-93D5-48E7-9EF0-FF422ED8B5D5

Q36037975-127EB0A5-4114-4D4F-9C94-E697AB11583F

Q36037975-17A94DE3-27ED-4434-A5D1-A187A7D2897C

Q36037975-199F3F60-6AB9-437F-A328-3DF04136FF0A

Q36037975-1FB0A7EE-FECA-427C-B87D-71FF227BE44F

Q36037975-205D4D17-0326-4178-9102-9DF8A1787A66

Q36037975-22890B6D-AE76-4399-B94B-00D5F95BD508

Q36037975-2E4A7B7C-9040-4DD6-8792-C823DB3BFEA4

Q36037975-2E8247A8-EE59-4126-ACD3-2FD58ED431B0

P304

Q36037975-7EE21DDD-897B-456E-A25A-927987A8AED8

P31

Q36037975-60CB293B-8304-46CC-9271-33D24C48DD22

P356

Q36037975-225791B5-9B64-4C56-BB5F-05761484BBFD

P433

Q36037975-C0BABC44-BEF8-4FB2-BADA-29DD678CC473

P478

Q36037975-99652C73-D22E-46DC-BD93-CAC534DE4B08

P577

Q36037975-2722EB41-6081-4836-A05F-75A766E485D2

P5875

Q36037975-44680EA4-CC61-4DC7-9CD8-00BFF547DF6E

P698

Q36037975-906E1417-F43A-4B3D-AA70-B83F0624A6B3

P932

Q36037975-E7C712C4-54A7-44F3-B4E6-E6E48BA9F346

P356

P1433

EMBO Molecular Medicine

P1476

Tumour growth inhibition and a ...... sistant Semaphorin 3E isoform.

@en

P2093

Andrea Casazza

http://www.w3.org/2001/XMLSchema#string

Boaz Kigel

http://www.w3.org/2001/XMLSchema#string

Enrico Giraudo

http://www.w3.org/2001/XMLSchema#string

Federica Maione

http://www.w3.org/2001/XMLSchema#string

Gera Neufeld

http://www.w3.org/2001/XMLSchema#string

Lorena Capparuccia

http://www.w3.org/2001/XMLSchema#string

Luca Tamagnone

http://www.w3.org/2001/XMLSchema#string

Massimiliano Mazzone

http://www.w3.org/2001/XMLSchema#string

Ofra Kessler

http://www.w3.org/2001/XMLSchema#string

P2860

Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels

Transcription of a novel mouse semaphorin gene, M-semaH, correlates with the metastatic ability of mouse tumor cell lines

Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis

Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors

Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

The Semaphorin 4D receptor Plexin-B1 is a GTPase activating protein for R-Ras

Semaphorin 3E and plexin-D1 control vascular pattern independently of neuropilins

Semaphorin 3E initiates antiangiogenic signaling through plexin D1 by regulating Arf6 and R-Ras.

Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis

Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors

P304

234-250

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/EMMM.201100205

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221749292

http://www.w3.org/2001/XMLSchema#string

P698

22247010

http://www.w3.org/2001/XMLSchema#string

P932

3376853

http://www.w3.org/2001/XMLSchema#string